Efficient species CHAdV infectivity in plasmocytic cell lines using a clathrin-inclependent lipid raft/caveola endocytic route

被引:32
作者
Colin, M [1 ]
Mailly, L [1 ]
Rogée, S [1 ]
D'Halluin, JC [1 ]
机构
[1] Inst Rech Canc Lille, INSERM, U524, IMPRT, F-59045 Lille, France
关键词
adenovirus; clathrin; caveolae; lipid raft; endocytosis; gene transfer; hematopoietic cell lines;
D O I
10.1016/j.ymthe.2004.10.007
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hematopoietic cells are known to be refractory to species C human adenovirus (HAdV) infection; however, the reason for this has not been clearly established. We have previously demonstrated that this nonpermissivity is the consequence of inefficient HAdV particle uptake, notably in B lymphocytes. We noted that while the protein clathrin is observed in association with membranes in epithelial cells, it is found predominantly in the cytoplasm of hematopoietic cell lines. So it appears that altered clathrin-coated pit endocytosis could explain the weak HAdV uptake in B cells. In contrast, mature B cell plasmocytes are permissive to HAdV. However, this is not the result of clathrin-coated pit endocytosis since this process is also inefficient in these cells. Confocal microscopy showed colocalization between HAdV particles and caveolae/lipid rafts in plasmocytes. Moreover, inhibiting caveola enclocytosis by depletion of cholesterol or expression of dominant negative caveolin-1 in these cells results in a 50-70% reduction in HAdV infectivity. It appears that caveola enclocytosis and nonclathrin noncaveola enclocytosis are used by HAdV to enter plasmocytes in response to a loss of the clathrin-dependent pathway. Thus targeting of caveolae by modifying the capsid of HAdV may represent an alternative approach to enhancing uptake in most hematopoietic cells for future gene therapy.
引用
收藏
页码:224 / 236
页数:13
相关论文
共 73 条
  • [1] Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process
    Abrami, L
    Liu, SH
    Cosson, P
    Leppla, SH
    van der Goot, FG
    [J]. JOURNAL OF CELL BIOLOGY, 2003, 160 (03) : 321 - 328
  • [2] MUTATIONS THAT ALTER AN ARG-GLY-ASP (RGD) SEQUENCE IN THE ADENOVIRUS TYPE-2 PENTON BASE PROTEIN ABOLISH ITS CELL-ROUNDING ACTIVITY AND DELAY VIRUS REPRODUCTION IN FLAT CELLS
    BAI, M
    HARFE, B
    FREIMUTH, P
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (09) : 5198 - 5205
  • [3] Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
    Bergelson, JM
    Cunningham, JA
    Droguett, G
    KurtJones, EA
    Krithivas, A
    Hong, JS
    Horwitz, MS
    Crowell, RL
    Finberg, RW
    [J]. SCIENCE, 1997, 275 (5304) : 1320 - 1323
  • [4] DECAY-ACCELERATING FACTOR (CD55), A GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED COMPLEMENT REGULATORY PROTEIN, IS A RECEPTOR FOR SEVERAL ECHOVIRUSES
    BERGELSON, JM
    CHAN, M
    SOLOMON, KR
    STJOHN, NF
    LIN, HM
    FINBERG, RW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (13) : 6245 - 6248
  • [5] Burger JA, 2000, BLOOD, V96, P2655
  • [6] Structure of adenovirus complexed with its internalization receptor, αvβ5 integrin
    Chiu, CY
    Mathias, P
    Nemerow, GR
    Stewart, PL
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (08) : 6759 - 6768
  • [7] Cell delivery, intracellular trafficking and expression of an integrin-mediated gene transfer vector in tracheal epithelial cells
    Colin, M
    Maurice, M
    Trugnan, G
    Kornprobst, M
    Harbottle, RP
    Knight, A
    Cooper, RG
    Miller, AD
    Capeau, J
    Coutelle, C
    Brahimi-Horn, MC
    [J]. GENE THERAPY, 2000, 7 (02) : 139 - 152
  • [8] Factors involved in the sensitivity of different hematopoietic cell lines to infection by subgroup C adenovirus: implication for gene therapy of human lymphocytic malignancies
    Colin, M
    Renaut, L
    Mailly, L
    D'Halluin, JC
    [J]. VIROLOGY, 2004, 320 (01) : 23 - 39
  • [9] Integrin alpha 5 beta 1-mediated adenovirus infection is enhanced by the integrin-activating antibody TS2/16
    Davison, E
    Diaz, RM
    Hart, IR
    Santis, G
    Marshall, JF
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (08) : 6204 - 6207
  • [10] Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5
    Dechecchi, MC
    Melotti, P
    Bonizzato, A
    Santacatterina, M
    Chilosi, M
    Cabrini, G
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (18) : 8772 - 8780